Skip to main navigation
Close
Menu
Main navigation
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action
Breadcrumb
Association for Accessible Medicines
Resources
Resources
Share
Find up-to-date information on generics and biosimilars
Filter Resources
Issues
Biosimilar User Fee Act (BsUFA)
Biosimilars
Complex Generics
Drug Approval Process (GDUFA)
Drug Prices
Drug Shortages
Generic Drug Labeling
Generic Supply Chain
IP Issues
Low Income Subsidies (LIS in Part D)
Medicaid
Medicare
NAFTA
Patent Reform
Patient Stories
Pharmaceutical Waste Take Back
Preventing Drug Abuse
Quality
REMS/Sample Acquisition Remedies
State Initiatives
Tariffs
Trade
Transparency
User Fees
Resource Type
Blog
Amicus Brief
Press Release
Infographic
Video
Report
Fact Sheet
Presentation
Blog
Feb 16, 2022
| Jewel Smith
Black History Month: 10 Pioneers to Celebrate
Press Release
Feb 15, 2022
| Rachel Schwartz
AAM Statement on the Confirmation of Robert Califf to Lead FDA
Press Release
Feb 15, 2022
| Rachel Schwartz
Academy of Managed Care Pharmacy Named AAM’s 2022 Champion of Access
Press Release
Feb 14, 2022
| Rachel Schwartz
Chirag Patel Named Chair of the Association for Accessible Medicines Board of Directors
Press Release
Feb 14, 2022
| Rachel Schwartz
AAM Announces 2022 Board of Directors
Press Release
Feb 14, 2022
| Rachel Schwartz
AAM Announces 2022 Associate Members
Report
Feb 10, 2022
| Dan Leonard
AAM Voices of Access 2022
Video
Feb 10, 2022
| Erica Klinger
Biosimilars Council — Leading on Biosimilars for America's Patients
Blog
Feb 9, 2022
| Erica Klinger
State of the Union: Generic and Biosimilar Savings for States and Taxpayers
Blog
Feb 6, 2022
| Aquera Agee
Seven Reasons to Join Us for Access! 2022
Fact Sheet
Feb 4, 2022
| Erica Klinger
Cancer Patients Save $16 Billion Per Year with Generics and Biosimilars
Press Release
Feb 2, 2022
| Rachel Schwartz
AAM Statement on FDA User Fee Reauthorization
Load More
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Access! 2024
GRx+Biosims 2023
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action